105 related articles for article (PubMed ID: 227570)
1. Adriamycin, BCNU plus cyclophosphamide (ABC) in advanced carcinoma of the head and neck.
Presant CA; Ratkin G; Klahr C; Brown C
Cancer; 1979 Nov; 44(5):1571-5. PubMed ID: 227570
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy of advanced prostatic cancer with adriamycin, BCNU, and cyclophosphamide.
Presant CA; Van Amburg A; Klahr C; Metter GE
Cancer; 1980 Dec; 46(11):2389-92. PubMed ID: 7438014
[TBL] [Abstract][Full Text] [Related]
3. Adriamycin, 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU-NSC 409462), and cyclophosphamide in refractory adenocarcinoma of the breast and other tumors.
Presant CA; Kolhouse JF; Klahr C
Cancer; 1976 Feb; 37(2):620-8. PubMed ID: 1253101
[TBL] [Abstract][Full Text] [Related]
4. Adriamycin, 1,3-bis (2-chloroethyl) 1 nitrosourea (BCNU, NSC No. 409962), cyclophosphamide plus prednisone (ABC-P) in melphalanresistant multiple myeloma.
Presant CA; Klahr C
Cancer; 1978 Sep; 42(3):1222-7. PubMed ID: 698913
[TBL] [Abstract][Full Text] [Related]
5. Adriamycin, BCNU, ftorafur chemotherapy of pancreatic and biliary tract cancer.
Hall SW; Benjamin RS; Murphy WK; Valdivieso M; Bodey GP
Cancer; 1979 Dec; 44(6):2008-13. PubMed ID: 389404
[TBL] [Abstract][Full Text] [Related]
6. Feasibility study of combining metronidazole with chemotherapy.
Stewart DJ; Maroun JA; Young V; Crook AF; Hopkins HS; Yan RC; Richard MT; Hugenholtz H; Bélanger R; Heringer R
J Clin Oncol; 1983 Jan; 1(1):17-23. PubMed ID: 6422002
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy for advanced head and neck cancer with the combination adriamycin, cyclophosphamide, and cis-diamminedichloroplatinum (II): preliminary assessment of a one-day vs. three-day drug regimen.
Creagan ET; Fleming TR; Edmonson JH; Ingle JN; Woods JE
Cancer; 1981 Jun; 47(11):2549-51. PubMed ID: 7196281
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC No. 409962) with amphotericin B in bronchogenic carcinoma.
Presant CA; Hillinger S; Klahr C
Cancer; 1980 Jan; 45(1):6-10. PubMed ID: 6243243
[TBL] [Abstract][Full Text] [Related]
9. Adriamycin, 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC 409962) and cyclophosphamide therapy of drug-resistant metastatic breast carcinoma.
Presant CA; Van Amburg A; Klahr C
Cancer; 1977 Sep; 40(3):987-93. PubMed ID: 902247
[TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy for bronchogenic carcinoma with doxorubicin, BCNU, and cyclophosphamide (ABC): a pilot study of the Southeastern Cancer Study Group.
Denes AE; Presant CA; Bartolucci A
Cancer Treat Rep; 1982 Jan; 66(1):199-200. PubMed ID: 7053258
[No Abstract] [Full Text] [Related]
11. Intensive induction therapy for small cell carcinoma of the lung.
Abeloff MD; Ettinger DS; Khouri NF; Lenhard RE
Cancer Treat Rep; 1979 Apr; 63(4):519-24. PubMed ID: 221117
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy for recurrent adeno- and adenoidcystic carcinomas in the head and neck.
Tsukuda M; Kokatsu T; Ito K; Mochimatsu I; Kubota A; Sawaki S
J Cancer Res Clin Oncol; 1993; 119(12):756-8. PubMed ID: 8408188
[TBL] [Abstract][Full Text] [Related]
13. Clinical phase I study of paclitaxel followed by cisplatin in advanced head and neck squamous cell carcinoma.
Hanauske AR; Schilling T; Heinrich B; Kau R; Herzog M; Quasthoff S; Bochtler H; Diergarten K; Rastetter J
Semin Oncol; 1995 Dec; 22(6 Suppl 14):35-9. PubMed ID: 8553082
[TBL] [Abstract][Full Text] [Related]
14. A phase I-II trial of carboplatin and 5-fluorouracil combination chemotherapy in advanced carcinoma of the head and neck.
Forastiere AA; Natale RB; Takasugi BJ; Goren MP; Vogel WC; Kudla-Hatch V
J Clin Oncol; 1987 Feb; 5(2):190-6. PubMed ID: 3543242
[TBL] [Abstract][Full Text] [Related]
15. Adriamycin, BCNU, and cyclophosphamide in drug-resistant adenocarcinoma of the ovary.
Presant CA; Bartolucci A
Med Pediatr Oncol; 1983; 11(3):151-3. PubMed ID: 6682929
[TBL] [Abstract][Full Text] [Related]
16. Polychemotherapy with carmustine, cyclophosphamide plus adriamycin in the treatment of advanced ovarian cancer.
Facchini V; Gadducci A; Bogi G; Colombi L; Basile AG; Ballantini M; De Pasquale F; Fioretti P
Eur J Gynaecol Oncol; 1985; 6(1):37-40. PubMed ID: 4038650
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of etoposide and doxorubicin in advanced head and neck cancer.
Gradishar WJ; Vokes EE; Kies MS
Med Pediatr Oncol; 1990; 18(6):487-90. PubMed ID: 2233521
[TBL] [Abstract][Full Text] [Related]
18. Sequential combination chemotherapy for advanced squamous cell carcinoma of the head and neck.
Lester EP; Kinnealey A; Matz GJ
Laryngoscope; 1979 Dec; 89(12):1921-9. PubMed ID: 92740
[TBL] [Abstract][Full Text] [Related]
19. A randomized comparison of doxorubicin alone versus doxorubicin plus cyclophosphamide in the management of advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group study.
Thigpen JT; Blessing JA; DiSaia PJ; Yordan E; Carson LF; Evers C
J Clin Oncol; 1994 Jul; 12(7):1408-14. PubMed ID: 8021731
[TBL] [Abstract][Full Text] [Related]
20. Combination chemotherapy of head and neck cancer.
Holoye PY; Byers RM; Gard DA; Goepfert H; Guillamondegui OM; Jesse RH
Cancer; 1978 Oct; 42(4):1661-9. PubMed ID: 81714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
